The COVID-19 pandemic has presented major challenges for biomedical treatment and research, including the field of noninvasive brain stimulation, or NIBS.
In a new article published in the journal Brain Stimulation experts offer strategies and guidelines for clinical and research applications of transcranial magnetic stimulation, or TMS, and low intensity transcranial electrical stimulation, or tES, during the COVID-19 crisis.
“There is an evident, and in cases urgent, need to maintain NIBS operations through the COVID-19 pandemic, including anticipating future pandemic waves and addressing effects of COVID-19 on brain and mind,” write the authors, including Adam J. Woods, Ph.D., associate director of UF’s Center for Cognitive Aging and Memory and an associate professor of clinical and health psychology in the College of Public Health and Health Professions.